In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors.
暂无分享,去创建一个
[1] J. Thompson,et al. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[3] R. Blasberg,et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] G. Linette,et al. Antimelanoma Activity of CTL Generated from Peripheral Blood Mononuclear Cells After Stimulation with Autologous Dendritic Cells Pulsed with Melanoma gp100 Peptide G209-2M Is Correlated to TCR Avidity , 2002, The Journal of Immunology.
[5] Lieping Chen,et al. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells. , 2002, Cancer research.
[6] Ralph Weissleder,et al. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. , 2002, Bioconjugate chemistry.
[7] C. Semsarian. Stem cells in cardiovascular disease: from cell biology to clinical therapy , 2002, Internal medicine journal.
[8] F. Luscinskas,et al. Neutrophils from MMP‐9‐ or neutrophil elastase‐deficient mice show no defect in transendothelial migration under flow in vitro , 2002, Journal of leukocyte biology.
[9] C. Fournier,et al. Syngeneic fibroblasts transfected with a plasmid encoding interleukin‐4 as non‐viral vectors for anti‐inflammatory gene therapy in collagen‐induced arthritis , 2002, The journal of gene medicine.
[10] B. Barlogie,et al. Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy. , 2002, Blood.
[11] G. Marchal,et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) – results of a phase-III multicenter clinical trial , 2002, European Radiology.
[12] G. Kossoy,et al. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distribution of T lymphocytes in tumors. , 2002, International journal of molecular medicine.
[13] R. Weissleder,et al. MRI of insulitis in autoimmune diabetes , 2002, Magnetic resonance in medicine.
[14] Alan Dove,et al. Cell-based therapies go live , 2002, Nature Biotechnology.
[15] Dai Fukumura,et al. Dissecting tumour pathophysiology using intravital microscopy , 2002, Nature Reviews Cancer.
[16] Michael E. Phelps,et al. Ex vivo cell labeling with 64Cu–pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Acres,et al. Improvement of adoptive cellular immunotherapy of human cancer using ex-vivo gene transfer. , 2002, Current gene therapy.
[18] J. Prieto,et al. Cytokine gene transfer into dendritic cells for cancer treatment. , 2002, Current gene therapy.
[19] S. Petit-Zeman,et al. Regenerative medicine , 2001, Nature Biotechnology.
[20] Peter van Gelderen,et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.
[21] C. Contag,et al. Bioluminescence imaging of lymphocyte trafficking in vivo. , 2001, Experimental hematology.
[22] B. Johnstone,et al. Mesenchymal cell transfer for articular cartilage repair , 2001, Expert opinion on biological therapy.
[23] M. Peshwa,et al. Dendritic cell-based treatment of cancer: closing in on a cellular therapy. , 2001, Cancer journal.
[24] L. Álvarez-Vallina. Genetic approaches for antigen-selective cell therapy. , 2001, Current gene therapy.
[25] R Weissleder,et al. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. , 2001, Journal of immunological methods.
[26] A. Söling,et al. Dendritic Cell Therapy of Primary Brain Tumors , 2001, Molecular medicine.
[27] Hans J. Stauss,et al. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer , 2001, Nature Immunology.
[28] A. Rickinson,et al. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. , 2001, Cancer research.
[29] J. Yewdell,et al. Multiple Paths for Activation of Naive CD8+ T Cells: CD4-Independent Help1 , 2001, The Journal of Immunology.
[30] S. Riddell,et al. In vivo tracking of tumor-specific T cells. , 2001, Current opinion in immunology.
[31] D. Brown,et al. Tumours can act as adjuvants for humoral immunity , 2001, Immunology.
[32] R. Mitchell,et al. CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection. , 2001, Transplantation.
[33] S. Gautam,et al. IL-12 gene therapy of leukemia with hematopoietic progenitor cells without the toxicity of systemic IL-12 treatment. , 2001, Clinical immunology.
[34] R. Schreiber,et al. Eradication of established tumors by CD8+ T cell adoptive immunotherapy. , 2000, Immunity.
[35] Ralph Weissleder,et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.
[36] J A Frank,et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Sallan,et al. Adoptive T-cell therapy for B-cell acute lymphoblastic leukemia: preclinical studies. , 1999, Blood.
[38] S. Rosenberg,et al. Human tumor antigens for cancer vaccine development , 1999, Immunological reviews.
[39] R. Dutton,et al. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases. , 1999, Journal of immunology.
[40] P. Romero,et al. An antigen-targeted approach to adoptive transfer therapy of cancer. , 1999, Cancer research.
[41] R Weissleder,et al. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.
[42] U. Wahn,et al. Specific V beta T cell subsets are associated with cat and birch pollen allergy in humans. , 1999, Journal of immunology.
[43] R. Burt,et al. Hematopoietic stem cell therapy of autoimmune diseases. , 1998, Current opinion in hematology.
[44] A. Moisan,et al. Autologous human macrophages and anti-tumour cell therapy. , 1998, Research in immunology.
[45] E. Snyder,et al. Remyelination: cellular and gene therapy. , 1998, Seminars in pediatric neurology.
[46] D. V. van Bekkum. Autologous stem cell therapy for treatment of autoimmune diseases. , 1998, Experimental hematology.
[47] A. Cesano,et al. Cell therapy of a highly invasive human breast carcinoma implanted in immunodeficient (SCID) mice. , 1997, Clinical Cancer Research.
[48] M. Lotze,et al. Dendritic cell based therapy of cancer. , 1997, Advances in experimental medicine and biology.
[49] M. Lotze,et al. Dendritic Cell Based Therapy of Cancer , 1997 .
[50] I. Weissman,et al. Flow cytometric identification of murine neutrophils and monocytes. , 1996, Journal of immunological methods.
[51] J. Banchereau,et al. Dendritic Cells in Fundamental and Clinical Immunology , 2012, Advances in Experimental Medicine and Biology.
[52] T. Irimura,et al. Real-time PET analysis of metastatic tumor cell trafficking in vivo and its relation to adhesion properties. , 1995, Biochimica et biophysica acta.
[53] Kristin A. Hogquist,et al. T cell receptor antagonist peptides induce positive selection , 1994, Cell.